Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:418-423
Published online before print November 4, 2004, doi: 10.1161/01.ATV.0000149379.72018.20
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/2/418    most recent
01.ATV.0000149379.72018.20v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyriakou, T.
Right arrow Articles by Ye, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyriakou, T.
Right arrow Articles by Ye, S.
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Genetics of cardiovascular disease
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:418.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Genotypic Effect of the –565C>T Polymorphism in the ABCA1 Gene Promoter on ABCA1 Expression and Severity of Atherosclerosis

Theodosios Kyriakou; Conrad Hodgkinson; David E. Pontefract; Srikanth Iyengar; W. Martin Howell; Yuk-ki Wong; Per Eriksson; Shu Ye

From the Human Genetics Division (T.K., C.H., D.E.P., W.M.H., S.Y.), School of Medicine, University of Southampton, Southampton, UK; the Cardiothoracic Unit (D.E.P., S.I., Y.W.), Southampton General Hospital, Southampton, UK; and the Atherosclerosis Research Unit (P.E.), King Gustaf V Research Institute, Karolinska Hospital, Stockholm, Sweden.

Correspondence to Dr Shu Ye, Human Genetics Division, Duthie Building (mp 808), Southampton General Hospital, Southampton SO16 6YD, United Kingdom. E-mail Shu.Ye{at}soton.ac.uk

Objective— Loss-of-function mutations of the ATP-binding cassette transporter A1 (ABCA1) gene cause Tangier disease, a rare genetic disorder with accumulation of lipid-laden macrophages and increased risk of atherosclerosis. Common variants of this gene may be a genetic factor for atherosclerosis in the general population. This study was performed to test the reported association between the –565C>T polymorphism and atherosclerosis severity and to investigate whether this variant per se had an effect on promoter activity of the ABCA1 gene.

Methods and Results— A cohort of patients with coronary atherosclerosis were genotyped for the –565C>T polymorphism. Logistic regression analyses showed that homozygotes of the –565T allele had greatest mean number of diseased coronary arteries, particular in nonsmokers. Real-time reverse-transcriptase polymerase chain reaction showed that in atherosclerotic plaques removed from patients undergoing endarteretomy, ABCA1 expression levels were lowest in those who had the T/T genotype and highest in those of the C/C genotype. Transfection and reporter assays demonstrated that in cultured macrophages, the –565T allelic promoter had a lower activity in driving gene expression than the –565C allelic promoter. Electrophoretic mobility shift assays displayed differential binding of nuclear proteins to the 2 alleles.

Conclusions— These results indicate that the –565C>T polymorphism has an allele-specific effect on ABCA1 gene expression and provide further evidence of a genotypic effect on coronary atherosclerosis severity.

The study showed that the ABCA1 gene –565C>T polymorphism was associated with severity of coronary atherosclerosis in a cohort of patients from Southern England and that this sequence variant per se had an effect on promoter activity of the ABCA1 gene. The data support the notion that common ABCA1 gene variants can contribute to interindividual variability in atherosclerosis susceptibility and severity.


Key Words: ABCA1 • genetics • promoter • polymorphism • atherosclerosis




This article has been cited by other articles:


Home page
StrokeHome page
Y. Yamada, N. Metoki, H. Yoshida, K. Satoh, K. Kato, T. Hibino, K. Yokoi, S. Watanabe, S. Ichihara, Y. Aoyagi, et al.
Genetic Factors for Ischemic and Hemorrhagic Stroke in Japanese Individuals
Stroke, August 1, 2008; 39(8): 2211 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
T. Kyriakou, D. E. Pontefract, E. Viturro, C. P. Hodgkinson, R. C. Laxton, N. Bogari, G. Cooper, M. Davies, J. Giblett, I. N.M. Day, et al.
Functional polymorphism in ABCA1 influences age of symptom onset in coronary artery disease patients
Hum. Mol. Genet., June 15, 2007; 16(12): 1412 - 1422.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-i. Okuhira, M. L. Fitzgerald, D. A. Sarracino, J. J. Manning, S. A. Bell, J. L. Goss, and M. W. Freeman
Purification of ATP-binding Cassette Transporter A1 and Associated Binding Proteins Reveals the Importance of {beta}1-Syntrophin in Cholesterol Efflux
J. Biol. Chem., November 25, 2005; 280(47): 39653 - 39664.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Pearce, D.-A. Tregouet, A. Samnegard, A. R. Morgan, C. Cox, A. Hamsten, P. Eriksson, and S. Ye
Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction
Circ. Res., November 11, 2005; 97(10): 1070 - 1076.
[Abstract] [Full Text] [PDF]